Assessment of severity and pattern of irreversible organ damage in patients with systemic lupus erythematosus and systemic scleroderma
https://doi.org/10.33667/2078-5631-2019-1-18(393)-30-33
Abstract
The article is devoted to the study of the degree and pattern of irreversible changes in the organs and systems of the body using the SLICC damage index in patients with systemic lupus erythematosus (SLE) and systemic scleroderma (SSc) with a disease duration of more than 5 years. Data were obtained from a high incidence of adverse changes in patients with SLE and SSc. In patients with SLE, adverse changes in the cardiovascular system, central nervous system in the form of acute cerebral circulation disorders and seizures, as well as venous thrombosis, damage to the organ of vision in the form of cataracts, proteinuria (more than 3.5 g per day) and alopecia prevailed. Patients with SSc more often developed lesions of the respiratory organs in the form of pulmonary fibrosis and pulmonary hypertension, the musculoskeletal system, skin and neuropathy of the cranial nerves and peripheral nerves.
About the Authors
A. V. Petrov
Medical academy n. a. S. I. Georgievsky of Crimean Federal University n. a. V. I. Vernadsky
Russian Federation
Simferopol
Russian Federation
Simferopol
A. S. Gaffarova
Medical academy n. a. S. I. Georgievsky of Crimean Federal University n. a. V. I. Vernadsky
Russian Federation
Simferopol
Russian Federation
Simferopol
References
1. Strand V, Gladman D, Isenberg D, et al. Outcome measures to be used in clinical trials in systemic lupus erythematosus. J Rheumatol. 1999 Feb; 26 (2): 490–7.
2. Joannidis J., Vlachoyiannopolos P., Haidich A. et al. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 2005; 118: 2–10.
3. Gladman DD, Ginzler E, Goldsmith C, et al. The development and initial validation of the systemic lupus international collaborating clinics / American college of rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996 Mar; 39 (3): 363–9.
4. Gladman DD, Urowitz MB, Goldsmith CH, et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index in patients with systemic lupus erythematosus. Arthritis Rheum. 1997 May; 40 (5): 809–13.
5. Gladman DD, Goldsmith CH, Urowitz MB, et al. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) damage index for systemic lupus erythematosus inter-national comparison. J Rheumatol. 2000 Feb; 27 (2): 373–6.
6. Andrianova IA, Ivanova MM. Early damage index in systemic lupus erythematosus. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2005; 43 (5): 19–22 (In Russ.) DOI: 10.14412/1995–4484–2005–35.
7. Tarasova IA. Znachenie indeksa povrezhdeniya v prognozirovanii iskhoda sistemnoi krasnoi volchanki. Diss. … kand. med. nauk [The value of damage index in predicting the outcome of systemic lupus erythematosus. Diss. … Cand. Med. Sci. Moscow; 2003. 140 p.
8. Valentini G., Della Rossa A., Bombardieri S. et al. European multicentre study to gefine criteria for systemic sclerosis. II. Indification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 2001; 60: 592–8.
9. Becker-Merok A, Nossent HC. Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality. J Rheumatol. 2006; 33 (8): 1570–7.
10. Gladman DD, Urowitz MB, Rahman P, et al. Accrual of organ damage over time in patients with systemic lupus erythematosus. J Rheumatol. 2003; 30 (9): 1955–9.
11. Sutton EJ, Davidson JE, Bruce IN. The systemic lupus international collaborating clinics (SLICC) damage index: a systematic literature review. Semin Arthritis Rheum. 2013 Dec; 43 (3): 352–61. DOI: 10.1016/j.semarthrit.2013.05.003.
12. Valentini G., Bencivelli W., Bombardieri S. et al. European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria. Ann Rheum Dis 2003; 62: 901–3.
13. Асеева ЕА, Соловьев СК, Клюквина НГ и др. Необратимые органные повреждения в когорте пациентов с системной красной волчанкой (РЕНЕССАНС). Научно-практическая ревматология. 2016; 54 (4): 404–411.
Review
For citations:
Petrov A.V., Gaffarova A.S. Assessment of severity and pattern of irreversible organ damage in patients with systemic lupus erythematosus and systemic scleroderma. Medical alphabet. 2019;1(18):30-33. (In Russ.) https://doi.org/10.33667/2078-5631-2019-1-18(393)-30-33
Views:
445
Email this article 